checkAd
    Startseite > Aktien > Athira Pharma > Nachrichten
    Athira Pharma Aktie
    1,9600
     
    USD
    -3,92 %
    -0,0800 USD
    Letzter Kurs 02.05.24 Nasdaq
    1,9500
     
    USD
    1.700 STK
    Geldkurs 02.05.24
    1,9600
     
    USD
    600 STK
    Briefkurs 02.05.24
    ISIN: US04746L1044 · WKN: A2QCFW · SYM: ATHA · USA

    Neueste Nachrichten

    Athira Pharma to Participate in Upcoming May Conferences
    02.05.24 · globenewswire · Athira Pharma
    Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
    15.04.24 · globenewswire · Athira Pharma
    Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
    11.04.24 · globenewswire · Athira Pharma
    Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
    03.04.24 · globenewswire · Athira Pharma
    Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD 2024 International Conference
    08.03.24 · globenewswire · Athira Pharma
    Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
    22.02.24 · globenewswire · Athira Pharma
    Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
    08.02.24 · globenewswire · Athira Pharma
    Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
    08.01.24 · globenewswire · Athira Pharma
    Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
    03.01.24 · globenewswire · Athira Pharma
    Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
    29.11.23 · globenewswire · Athira Pharma
    Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND
    28.11.23 · globenewswire · Athira Pharma
    Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer’s Disease
    15.11.23 · globenewswire · Athira Pharma